This is the latest episode of the free DDW podcast, “What does gene-based medicine have to offer?”. It covers two narrated articles written for Volume 22, Issue 3 – Summer 2021 of DDW.
The articles are called “Lipidomics in biomedical research: chance and challenges” and “Exploring gene-based medicine’s true potential”.
In the first article, Afrisha Anderson, a Product Manager at Merck KGaA, discusses the opportunities and challenges in lipidomics. In the second article, Christopher...
Podcast: Is customisation healthcare’s secret weapon?
This is the latest episode of the free DDW podcast, “Is customisation healthcare’s secret weapon?”. It covers two narrated articles written for Volume 22, Issue 3 – Summer 2021 of DDW. The articles are called “Optimising vaccine production through customisation” and “Exploring iPSCs for individual and population health applications”.
In the first article, “Optimising vaccine production through customisation”, John Yoshi Shyu, Ph.D....
This episode covers three narrated articles written for Volume 22, Issue 3 – Summer 2021 and Volume 22, Issue 4 – Fall 2021 of DDW.
The articles are called “The benefits of bioinformatics in genomics sequencing” and “LIMs vs ELNs – what does your lab need?”, for which Part I and Part II were published separately across DDW issues.
Dr Bongcho Kim is the new CEO of Macrogen Europe, a Netherlands-based provider of genomic sequencing services. Dr Kim’s appointment comes at a time of...
The latest episode of the free DDW podcast is titled “A comprehensive analysis of European biotech”. It covers three narrated articles written for Volume 22, Issue 3 – Summer 2021 of DDW, read by Megan Thomas.
The articles are “Innovation and opportunity within Europe’s biotech sector”, “Europe’s emerging biotechs: Challenges, opportunities and funding”, and “Why Switzerland continues to punch above its weight as global biotech hub”.
In the first article, Lu Rahman introduces a slice of...
The latest episode of the free DDW podcast is titled“What do we know about lab automation?”. It covers two narrated articles written for Volume 22, Issue 3 – Summer 2021 of DDW, read by Megan Thomas. The articles are “What has 2020 taught us about lab automation?” and “Enhancing drug discovery with laboratory informatics and automation”.
In 2021, the first article looked back on 2020 and Dr Patrick Courtney from SiLA consortium, Burkhard Schaefer from SiLA consortium and ASTM AnIML, and...
The latest DDW Sitting Down With sponsored podcast features Dominque Bröhl and Evert-Jan Uringa, Scientific Program Managers at Taconic Biosciences who discuss how mouse model generation can be accelerated without any loss of quality.
The generation of genetically engineered custom mouse models can be a lengthy process that conflicts with the general time constraints of the drug discovery and development industry. Finding ways to shorten the time to create new mouse models is tempting but...
This is the latest episode of the free DDW podcast, “What can we learn from the genome?”. It covers two narrated articles written for Volume 22, Issue 3 – Summer 2021 of DDW and read aloud by Megan Thomas.
The articles are called “Reproducibility in single cell genomic analysis” and “The road to global pharmacogenomics”.
This episode is titled “From here to there: What lies ahead for drug discovery”, which covers two articles written for Volume 22, Issue 3 – Summer 2021 of DDW. They are called “The complexity of disease biology gives opportunities for drug discovery” and “The human touch: the benefits of real-world evidence”.
In the first article, Steve Gardner, CEO PrecisionLife, examines the lack of return on investment for pharmaceutical R&D and the huge pockets of unmet medical need in common chronic...
Medidata technology has helped to bring COVID-19 vaccines and treatments to market in record timelines and the company was the first to have launched a fully end-to-end Decentralised Clinical Trials (DCT) offering.
Decentralised clinical trials, described as the ‘new normal’ and the future of clinical research, harness remote technologies to enable patients to participate in clinical trials from their home or preferred location, decreasing patient burden and offering greater flexibility as...
In the first article, Nicola McCarthy from Horizon Discovery explains CRISPR–Cas as a gene knockout technology. In the second article, DDW Editor Lu Rahman looks at the role precision medicine is playing in how we approach the patient and the way we treat disease.
In the first article, Ian Linney and Scott Maidment from Charles River describe the value of integration of medicinal chemistry in high throughput screening. Caroline Horizny from Taconic Biosciences discusses mouse modelling in the second article.
In the first article, the authors explore applications of synthetic DNA in drug discovery and development, the benefits and limitations of current methods, and the opportunities offered by emerging DNA synthesis technologies.
In the wake of Covid-19 interest in repurposing a drug for a different indication to the one it was developed for has been high. In the second article, the authors offer insight into the process.
In the first article, DDW Editor Lu Rahman takes look at some of the latest imaging innovations available and how it can benefit drug target identification and drug discovery research.
In the second, Farah Patell-Socha, PhD, VP Research Products tells Lu Rahman about some of the company’s groundbreaking work in this field and the benefits it is creating for disease modelling and drug discovery.
Sophie Lutter, OXGENE, looks at the important role antibody therapeutics have to play and how, as the world has looked for Covid-19 treatments in the last year, their significance has been noted.
Toni Rogers and David Bunka, Aptamer Group discuss how newer antibody alternative technologies are demonstrating significant developments, offering novel solutions to improve success, decrease project timelines and produce innovative low-cost assays to small molecule targets across many sectors.
The latest sponsored DDW Sitting Down With podcast features Paul Wylie, Director of Multiplex at Abcam looking at enhancing the role of multiplexing in high-throughput screening.
Among the topics Lu Rahman will be discussing with Wylie will be the key challenges scientists face with biomarker and drug discovery and how high-throughput screening can help alleviate this.
Listen now to find out more.
The latest DDW Sitting Down With podcast features Bryan Jones, Senior Research Fellow, BioTechnology Discovery Research, Eli Lilly and Co and Dan Bedinger, Application Science Team Lead, Carterra.
Jones and Bedinger talk us through the Bamlanivimab story – and how one technology enabled this therapeutic to reach clinic in eight months during the pandemic.
The latest free-to-listen DDW podcast episode is titled “Recipe for success: collaboration in drug discovery”.
It covers three articles: “Why collaboration matters and how to make it a success”; “Platform biotechnologies and the art of collaboration”; and “Cell painting: a vibrant future for phenotypic drug discovery”.
This is the latest episode of the free DDW podcast: “Opportunities to improve drug discovery systems”. It covers two articles written for Volume 22, Issue 1 – Winter 2020/21 of the Drug Discovery World Magazine.
The first article is titled “Precision control of protein release to reconfigure bioprocessing and cell-based assays”. The second is called “Boosting pharmaceutical research with microbiome data”.
This is the latest episode of the free DDW podcast, “Putting virology back on the map: the fight against Covid-19”. It covers two articles written for Volume 22, Issue 1 – Winter 2020/21 of the Drug Discovery World Magazine.
The first article is a case study titled “New technology in COVID research may accelerate vaccines”, and the second is called “Virus in a well – microplate-based assays for virology research”.
John Couse, Vice President of Scientific Services at Taconic Biosciences discusses the benefits of a robust colony management solution/partner in the drug discovery success; how it can enable companies to scale through resource management and create efficiencies.
Couse has extensive knowledge of colony managements solutions and outlines the benefits they create for drug discovery researchers in terms of boosting efficiencies and achieving savings.
In this podcast Dr. Joanna Hawryluk discusses automating the cell culture workflow and explains the importance of cell culture workflow in the drug discovery process and how it can be improved thanks to technological advances.
Hawryluk talks us through the cell culture workflow and its relevance within the drug discovery process focussing on the areas that hold particular importance for this process.
This is the latest episode of the free DDW podcast, “Streamlining gene therapy manufacturing and how MS provides information on virus structure”.
The first article is titled, “Streamlining gene therapy manufacturing will help products reach more patients”, and the second article is titled, “It’s all in the technique: how MS provides information on virus structure and function”.
This is the latest episode of the free DDW podcast, “Stop, collaborate and listen: a model for successful pharma and vendor engagement”. It covers a narrated article written for DDW and read aloud by Megan Thomas.
This is the latest episode of the free DDW podcast, “Paving the way for optimum drug discovery”. It covers two narrated articles written for Volume 22, Issue 1 – Winter 2020/21
Of DDW and they are read aloud by Megan Thomas. These articles are titled: “In vitro models for assessing drug toxicity: new approaches and development” and “Accelerating assay development optimisation for drug discovery”.